Pharma API Yellowish Powder Purity 99%Min Dipyridamole CAS 58-32-2

Name: Pharma API Yellowish Powder Purity 99%Min Dipyridamole CAS 58-32-2
Brand: HUBEI SINOCHEM BIOTECH CO., LTD
SKU: 1978199941

Hubei, ChinaHUBEI SINOCHEM BIOTECH CO., LTD

US$230.00-250.00

25 GRAM

Product specifications

25KGS/DRUM

Product profile

Powder

Yes

Customized

Non-Customized

Certification

GMP, USP, BP

Model NO.

Suitable for

Adult

State

Solid

Purity

>99%

Transport Package

1g/Bottle

Specification

25/drum

Trademark

NONE

Origin

China

HS Code

2936

Production Capacity

150000

Company profile

Importers and Exporters

HUBEI SINOCHEM BIOTECH CO., LTD

Hubei, China

CertifiedBusiness Type: Trading Company CertifiedCustomization Options: Minor Customization CertifiedExport Year: 1 Year CertifiedNearest Port: Shanghai PortAverage Response Time: ≤7.03h CertifiedTerms of Payment: LC, T/T

AI-Powered supplier vetting

SummaryHubei Sinochem Biotech Co., Ltd. is identified as a trading company offering chemical products, biochemical technology services, new membrane materials, cosmetics, and related products. Its stated service infrastructure is limited: it has no overseas warehouse, showroom, overseas agent or branch, and no recorded participation in offline trade shows. Service procedures, complaint handling, and corrective/preventive-action records were not provided. The supplier reports no new products in the past year, no ODM, OEM, or SDK capability, and only one year of R&D engineer experience. No supplier management system certifications are listed. The available information does not establish production capability, customer references, or financial strength. An SGS audit is identified with validity from October 9, 2025 to October 8, 2026, but the stated evaluation result is 0 and no interpretation is provided.

Supplier typeThe supplier is explicitly classified as a trading company, with chemical products identified as its primary offered product. Its business scope also includes chemical-product sales, technical services, and technology-related activities, supporting a trading and technical-service profile rather than an expressly documented manufacturing profile.

CertificationsAn SGS audit is identified and its report period is stated as October 9, 2025 to October 8, 2026. However, the supplier management system certification field is listed as NIL, so no formal management-system certification is evidenced.

After-Sales capabilityThe supplier has no written procedures or records for service-capability assessment, corrective and preventive actions, or effective customer-complaint handling. It also reports no overseas warehouse, showroom, agent or branch, although it states a lead time of within 15 workdays and identifies Shanghai Port as the nearest service location.

R&D capabilityThe supplier states activities involving biochemical technology R&D, new materials technology, and new membrane materials, but also reports no new product in the past year, no ODM service, no SDK, and only one year of total R&D engineer experience. These records show some technical scope but do not demonstrate strong current innovation output.

Customization capabilityThe supplier explicitly reports that it does not provide ODM services and does not provide OEM services for popular brands. This is direct evidence of limited documented customization capability.